Home

Ozan Pamir

CIK 1834681 · Chief Financial Officer · last filed 2026-07-08

Ozan Pamir is a Chief Financial Officer who has filed 10 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing shows the insider was granted $11.5K of NAGE on Jul 8, 2026. Across all open-market trades the lifetime net is +$86.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $42.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$42.7K

Companies

3

Total Filings

10

Lifetime Open-Market Net

$86.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NAGE Chief Financial Officer 13,847 $3.08 $42.7K $45.6K 3 2026-07-08
Niagen Bioscience, Inc. (CDXC) Delisted Chief Financial Officer 2,907 $7.87 $22.9K $21.4K 3 2025-02-14
FORUM MARKETS Inc (ATNFW) Delisted CFO 8,983 $0.43 $3.9K $19.9K 4 2023-09-06

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-08 NAGE Grant (A) +4,255 $11.5K EDGAR
2026-02-24 NAGE Grant (A) — $0 EDGAR
2025-11-17 NAGE Buy (P) +6,685 $45.6K EDGAR
2025-02-14 Niagen Bioscience, Inc. (CDXC) Delisted Grant (A) — $0 EDGAR
2024-11-25 Niagen Bioscience, Inc. (CDXC) Delisted Buy (P) +2,907 $21.4K EDGAR
2024-10-23 Niagen Bioscience, Inc. (CDXC) Delisted Grant (A) — $0 EDGAR
2023-09-06 FORUM MARKETS Inc (ATNFW) Delisted Grant (A) — $0 EDGAR
2023-05-19 FORUM MARKETS Inc (ATNFW) Delisted Buy (P) +5,162 $5.2K EDGAR
2021-12-13 FORUM MARKETS Inc (ATNFW) Delisted Buy (P) +3,800 $14.7K EDGAR
2021-03-03 FORUM MARKETS Inc (ATNFW) Delisted Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.